January 23, 2026

Helping hands: Research team develops brace to reduce tremors

January 23, 2026 / Research update / InnovateMed Author / tremors

by Patty Wellborn, University of British Columbia edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Dr. Dylan Goode demonstrates the science behind the device that can help inhibit involuntary hand movement. Credit: University of British Columbia UBC Okanagan researchers have advanced their work on developing a noninvasive, accessible way to […]

Helping hands: Research team develops brace to reduce tremors Read More »

Going around health insurance

January 23, 2026 / News update / InnovateMed Author / health insurance

Illustration: Gabriella Turrisi/Axios Ditching health insurers and other intermediaries certainly has become a populist rallying cry among Republicans, but a subtler twist on the idea is already playing out. The big picture: The surge of weight loss drug sales not covered by traditional health insurance has proven the viability of direct-to-consumer health care that bypasses gatekeepers

Going around health insurance Read More »

New AI method revolutionizes the design of enzymes

January 23, 2026 / Research update / InnovateMed Author / enzymes

Researchers at Graz University of Technology and the University of Graz can use the technology to construct artificial biocatalysts. These new enzymes are significantly faster, more stable and more versatile than previous artificial biocatalysts Peer-Reviewed Publication Graz University of Technology image: From left: Adrian Tripp, Markus Braun and Gustav Oberdorfer from the Institute of Biochemistry

New AI method revolutionizes the design of enzymes Read More »

MAN PPK2: A “universal” enzyme for the production of RNA building blocks

January 23, 2026 / Research update / InnovateMed Author / RNA building block

Researchers use an ancient, energy-rich molecule for the low-cost synthesis of nucleotide triphosphates Peer-Reviewed Publication Institute of Science Tokyo image: A newly identified enzyme, MAN PPK2, acts as a universal catalyst that efficiently converts all common RNA nucleotides into nucleoside triphosphates. view more Credit: Institute of Science Tokyo A single enzyme that can generate all four

MAN PPK2: A “universal” enzyme for the production of RNA building blocks Read More »

Carbon-ion therapy spares surgery for early breast cancer

January 23, 2026 / Research update / InnovateMed Author / breast cancer

First prospective trial’s five-year results show excellent tumor control, minimal adverse effects, and preserved breast appearance Peer-Reviewed Publication The National Institutes for Quantum Science and Technology image: Typical dose distribution for carbon-ion radiotherapy in breast cancer and a representative case of right-sided breast cancer in a 61-year-old woman (T1cN0M0, tumor size 10 mm). Top panel: Carbon-ion

Carbon-ion therapy spares surgery for early breast cancer Read More »

This Biomarker May Be More Predictive of Cardiovascular Disease Than Cholesterol

January 23, 2026 / Research update / InnovateMed Author / cardiovascular disease

Sara Novak Doctors have long looked at certain risk factors including blood pressure, cholesterol, diabetes, smoking, and family history to predict a patient’s risk for cardiovascular disease. But increasingly, another lesser known biomarker, known as high-sensitivity C-reactive protein (hsCRP), seems to play an important role in whether a patient is at risk for a heart

This Biomarker May Be More Predictive of Cardiovascular Disease Than Cholesterol Read More »

Could a dietary supplement make the difference between life and death during illness?

January 23, 2026 / Research update / InnovateMed Author / dietary supplement

Salk Institute scientists uncover key role of kidneys in clearing inflammation from body, and show amino acid supplementation boosts this effect in mice Peer-Reviewed Publication Salk Institute image: Katia Troha (left), Christian Metallo (center left), Janelle Ayres (center right), and Shrikaar Kambhampati (right) discovered that an essential amino acid can boost kidney performance and clear

Could a dietary supplement make the difference between life and death during illness? Read More »

Experimental CAR T therapy targets tumor’s immune shield, not cancer cells directly

January 23, 2026 / Research update / InnovateMed Author / CAR T therapy

by The Mount Sinai Hospital edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Graphical abstract. Credit: Cancer Cell (2026). DOI: 10.1016/j.ccell.2025.12.021 Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells directly, it

Experimental CAR T therapy targets tumor’s immune shield, not cancer cells directly Read More »

Trojan horse’ may deliver toxic dose of copper to bacterial colonies, including drug-resistant MRSA infections

January 23, 2026 / Research update / InnovateMed Author / drug resistant MRSA infection

Peer-Reviewed Publication University of Arizona A research team at the University of Arizona College of Medicine – Tucson is developing a drug that works in combination with copper to kill bacteria, including those that cause MRSA, a type of staph infection that is resistant to usual treatments. They published their results last month in mSphere. MRSA is caused

Trojan horse’ may deliver toxic dose of copper to bacterial colonies, including drug-resistant MRSA infections Read More »

A research redefines the role of neutrophils and opens new avenues for cancer and inflammation therapies

January 23, 2026 / Research update / InnovateMed Author / cancer

Peer-Reviewed Publication Universidad Carlos III de Madrid image: Neutrophils accumulate in the alveoli of a lung infected with influenza. Image scale: 50 nanometers (one nanometer is one millionth of a millimeter). view more Credit: Iván Ballesteros/CNIC. Researchers from Universidad Carlos III de Madrid (UC3M), the National Center for Cardiovascular Research (CNIC), and Yale University (USA) have

A research redefines the role of neutrophils and opens new avenues for cancer and inflammation therapies Read More »